Skip to main content
Tech.euFundingExplorerBeta
Funding rounds/Osivax

Osivax

Series B
Lyon, FranceFounded 2017Mar 2025
Healthtech

Osivax raised €9.5M in a Series B round in Mar 2025. The company is based in Lyon, France. Investors in the round: Meiji Seika Pharma. Data as of Nov 2026.

← Osivax
Amount raised
€9.5M
€9,472,388
Native amount
10,000,000 USD
Stage
Series B
series b
Investors
1

Provenance & confidence

High confidence
Amount
10,000,000 USD
ECB-at-date → €9.5M · rate 1.0557 on 2025-03-04
High confidence
Source

finsmes.com · established

High confidence

Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.

Investors in this round

1 named
Meiji Seika Pharma
Date
Mar 2025
Round type
series b
Amount (EUR)
€9.5M

Other rounds

same company

Related news